Analystreport

Mesoblast Limited (NASDAQ: MESO) had its price target lowered by analysts at Chardan Capital from $6.50 to $2.50.

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com